Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer
Titel:
Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer
Auteur:
Eatock, M.M. Tebbutt, N.C. Bampton, C.L. Strickland, A.H. Valladares-Ayerbes, M. Swieboda-Sadlej, A. Van Cutsem, E. Nanayakkara, N. Sun, Y.-N. Zhong, Z.D. Bass, M.B. Adewoye, A.H. Bodoky, G.